For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Chemours Company’s stock clocked out at $19.09, up 1.60% from its previous closing price of $18.79. In other words, the price has increased by $1.60 from its previous closing price. On the day, 0.89 million shares were traded. CC stock price reached its highest trading level at $19.18 during the session, while it also had its lowest trading level at $18.6.
Ratios:
To gain a deeper understanding of CC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.92 and its Current Ratio is at 1.73. In the meantime, Its Debt-to-Equity ratio is 6.53 whereas as Long-Term Debt/Eq ratio is at 6.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on July 09, 2024, Upgraded its rating to Buy and sets its target price to $30 from $28 previously.
On June 07, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $25.
BMO Capital Markets Upgraded its Underperform to Outperform on April 09, 2024, whereas the target price for the stock was revised from $19 to $34.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 07 ’24 when Scarborough Alvenia sold 7,500 shares for $20.64 per share. The transaction valued at 154,771 led to the insider holds 16,645 shares of the business.
Scarborough Alvenia bought 7,500 shares of CC for $150,000 on Nov 06 ’24. On Aug 07 ’24, another insider, Picho Diane I., who serves as the Interim Pres. – Titanium Tech of the company, sold 2,684 shares for $18.82 each. As a result, the insider received 50,519 and left with 19,890 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CC now has a Market Capitalization of 2852256256 and an Enterprise Value of 6548246528. As of this moment, Chemours’s Price-to-Earnings (P/E) ratio for their current fiscal year is 41.73, and their Forward P/E ratio for the next fiscal year is 8.90. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.50 while its Price-to-Book (P/B) ratio in mrq is 4.34. Its current Enterprise Value per Revenue stands at 1.139 whereas that against EBITDA is 8.331.
Stock Price History:
The Beta on a monthly basis for CC is 1.80, which has changed by -0.3569473 over the last 52 weeks, in comparison to a change of 0.22677135 over the same period for the S&P500. Over the past 52 weeks, CC has reached a high of $32.48, while it has fallen to a 52-week low of $15.10. The 50-Day Moving Average of the stock is -1.03%, while the 200-Day Moving Average is calculated to be -12.31%.
Shares Statistics:
It appears that CC traded 1.72M shares on average per day over the past three months and 1670140 shares per day over the past ten days. A total of 149.39M shares are outstanding, with a floating share count of 148.63M. Insiders hold about 0.52% of the company’s shares, while institutions hold 82.01% stake in the company. Shares short for CC as of 1735603200 were 7389996 with a Short Ratio of 4.28, compared to 1732838400 on 7280091. Therefore, it implies a Short% of Shares Outstanding of 7389996 and a Short% of Float of 7.369999600000001.
Dividends & Splits
With its trailing 12-month dividend rate of 1.0, CC has a forward annual dividend rate of 1.00. Against a Trailing Annual Dividend Yield of 0.053219795The stock’s 5-year Average Dividend Yield is 4.13.
